General Information
Revision date
2018-02-15
Product name
Tenofovir Disoproxil Fumarate Tablets, 300 mg
1.2.1 Relevant identified uses
A nucleotide analog HIV-1 reverse transcriptase inhibitor and an HBV reverse transcriptase inhibitor
Manufacturer Name
Hetero Labs Limited
Icons in SDS
Company Information
company name
Camber Pharmaceuticals, Inc.
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H302+H312, H302+H312+H332
Hazard statements
Code
Statements
H302
Harmful if swallowed
H302+H312
Harmful if swallowed or in contact with skin
H302+H312+H332
Harmful if swallowed, in contact with skin or if inhaled
Section 2
CLP CLASSIFICATION
Classification according to Regulation (EC) No. 1272/2008 [CLP] ]] Not classified Classification according to Not classified Directive 67/548/EEC or 1999/45/EC
Adverse physicochemical, human health and environmental effects
Not classified
2.2 Label elements
Labelling according to Regulation (EC) No. 1272/2008 [CLP]
Signal word
Warning
Hazard statements
H302 - Harmful if swallowed H302+H312 - Harmful if swallowed or in contact with skin H302+H312+H332 - Harmful if swallowed, in contact with skin or if inhaled
Precautionary statements
P102 - Keep out of reach of children (CLP) P103 - Read label before use P202 - Do not handle until all safety precautions have been read and understood P222 - Do not allow contact with air P233 - Keep container tightly closed P234 - Keep only in original container P420 - Store aways from other materials
Supplemental label elements
EUH210 - Safety data sheet available on request
2.3 Other hazards
No additional information available